About SG Biomedical About SG Biomedical

ABOUT SG BIOMEDICAL

Innovating Biotech and Medical Device Technologies for a Better, Healthier Life

SG Biomedical focuses on expanding its presence in the Asian market across two key sectors: Medical Cold Plasma and Medical Intelligence.
In the field of Medical Cold Plasma, the company leverages innovative medical-grade cold plasma technology to treat a range of conditions—including acute and chronic large-scale wounds, chronic diabetic foot ulcers, surgical site infections, and infected burns. The significant therapeutic efficacy of this technology has been validated in over 82 professional medical journals worldwide. SG Biomedical is currently pursuing regulatory certifications and commercial expansion across Taiwan, six Southeast Asian nations, and other major Asian markets. As of June 2025, the company has formed a strategic equity alliance with a major U.S. biotechnology fund—a partnership spanning Taiwan, the U.K., the U.S., and Japan. Furthermore, the company has initiated the process for U.S. FDA certification while deepening its market penetration in Europe and Asia, all as part of a comprehensive strategy to establish a leading global commercial footprint in plasma medicine.
In the realm of Medical Intelligence, SG Biomedical is collaborating with major domestic medical institutions to develop Taiwan's first "Sovereign AI Large Language Model" for the healthcare sector. This initiative prioritizes data localization, model autonomy, and on-premises compliance. As the global digital landscape evolves rapidly, nations and specific industries are placing increasing emphasis on information security, geopolitics, and cultural localization. In healthcare—where medical records, genetic data, and clinical expertise constitute highly sensitive, core national assets—"Sovereign AI" has emerged as a pivotal market trend. SG Biomedical has established this specialized language model, using Taiwan's medical institutions as a foundational demonstration site, with plans for a phased rollout across the broader Asia-Pacific healthcare market.

關於施吉生技

BUSINESS PHILOSOPHY

經營理念
"Guided by the core values ​​of integrity and honesty, we remain steadfast in upholding our commitments to our customers, suppliers, employees, shareholders, and society."

In light of the long-term growth trends within the healthcare market, SG Biomedical remains committed to deepening the integration of its "Medical Cold Plasma" with "Medical Intelligence" applications. By combining cross-disciplinary technologies with established medical distribution channels, we aim to expand the use cases for our products and services, striving to deliver high-value healthcare solutions for the broader health and wellness industry.
Guided by our core values ​​of integrity and honesty, we remain steadfast in upholding our commitments to our clients, suppliers, employees, shareholders, and society at large. As we look toward the vast potential of the biotechnology and healthcare sector, SG Biomedical—fueled by deep passion and a firm dedication to the industry—looks forward to working alongside our employees to forge a future of limitless possibilities.

ORGANIZATION & KEY RESPONSIBILITIES

1. Organization
Board of Directors
Audit Department
Chairman's Office
 
General Manager's Office
 
Finance and Accounting Division
Operations
Division
 
R&D Center

 
Marketing
Center
 
2. Key Responsibilities

Chairman's
Office

  • Accountable to all shareholders, pursuant to resolutions of the Board of Directors.
  • Formulate the company's overall business objectives and execution plans.
  • Ensure the company's operational integrity and future strategic direction.
  • Approve major corporate decisions.

General
Manager's
Office

  • Responsible for steering the company's operational direction and business objectives; overseeing the planning and implementation of internal controls and budgeting systems, while monitoring operational performance; and providing input and consultation on research and development (R&D) initiatives.
  • Responsible for stakeholder planning and management; project evaluation, acquisition, and external licensing; the planning and execution of internal and external investments; and the drafting and management of contracts.

Audit
Department

  • Responsible for the company's internal audit affairs.

Finance and
Accounting
Division

  • Oversee the planning and execution of the company's financial and accounting affairs.
  • Manage the planning and execution of procurement—including raw materials and equipment—as well as inventory management.

Operations
Division

  • Oversee the planning and execution of functions including human resources, IT infrastructure and information security management, general administrative operations, document control and regulatory compliance, as well as the planning and management of product manufacturing processes.

R&D
Center

  • Responsible for technical research and development, as well as the design and creation of new medical device products. This includes formulating product research strategies, planning and executing product development, and conducting product verification and technical evaluations.

Marketing
Center

  • Responsible for medical device products planning, marketing, and customer service. Plans and executes the development of potential partnerships and market positioning.
Go To Top